Skip to main content
  • Checkpoint Inhibitors: Who Gets Myocarditis?

    FDA adverse event database analysis offers surprising clues

    The usual risk factors for myocarditis may not apply to who gets it while on immune checkpoint inhibiting cancer drugs, an FDA adverse event database suggested.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details